Demars Financial Group, LLC Bristol Myers Squibb CO Transaction History

Demars Financial Group, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$47.98 - $54.4 $474,906 - $538,451	-9,898 Reduced 65.76%	5,153 $279,000
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $3.03 Million - $3.62 Million	-62,519 Reduced 80.6%	15,051 $772,000
Q3 2023 Oct 18, 2023	BUY	$57.89 - $64.73 $426,417 - $476,801	7,366 Added 10.49%	77,570 $4.5 Million
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $22,107 - $24,546	-347 Reduced 0.49%	70,204 $4.49 Million
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $566,945 - $643,044	8,628 Added 13.93%	70,551 $4.89 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $289,738 - $343,091	-4,231 Reduced 6.4%	61,923 $4.45 Million
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $352 - $208,466	2,713 Added 4.28%	66,154 $4.7 Million
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $475,007 - $523,149	-6,541 Reduced 9.35%	63,441 $4.89 Million
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $487,905 - $585,041	7,936 Added 12.79%	69,982 $5.11 Million
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $218,917 - $255,206	4,082 Added 7.04%	62,046 $3.87 Million
Q3 2021 Oct 15, 2021	BUY	$59.17 - $69.31 $3.21 Million - $3.76 Million	54,255 Added 1462.79%	57,964 $3.43 Million
Q2 2021 Jul 16, 2021	SELL	$61.91 - $67.42 $7.38 Million - $8.03 Million	-119,140 Reduced 96.98%	3,709 $248,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $6.73 Million - $7.87 Million	122,849 New	122,849 $72,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Demars Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Demars Financial Group, LLC with notifications on news.